Gossamer Bio, Inc. (GOSS) earnings
GOSS earnings moved a median of -0.95% by the close. Quarterly and annual GOSS reports and results, each read against the price at its own news timestamp. Back to the GOSS overview →
23 measured GOSS earnings events.
Where these GOSS earnings landedvs 23 measured GOSS earnings reactions
| Middle 50% of GOSS earnings reactions | -8.23% to 0.00% |
|---|---|
| Median reaction (to close) | -0.95% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 GOSS earnings events with a measured close landed between -8.23% and +0.00%; 22% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Gossamer Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.50% | -9.29% | |
| Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update | Press release | -3.50% | -9.29% | |
| Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update | Press release | -12.97% | -35.77% | |
| Form 10-Q Gossamer Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -12.97% | -35.77% | |
| Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026 | Press release | +0.00% | +3.03% | |
| Form 10-K Gossamer Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.85% | -5.12% | |
| Form 10-Q Gossamer Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.08% | +0.00% | |
| Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.08% | +0.00% | |
| Form 10-Q Gossamer Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.62% | -7.48% | |
| Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update | Press release | -1.62% | -7.48% | |
| Form 10-Q Gossamer Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.95% | -0.95% | |
| Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study | Press release | -0.95% | -0.95% | |
| Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025 | Press release | +0.46% | +0.00% | |
| Form 10-K Gossamer Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.49% | +8.21% | |
| Form 10-Q Gossamer Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.58% | +1.02% | |
| Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update | Press release | +0.58% | +1.02% | |
| Form 10-Q Gossamer Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.00% | -0.05% | |
| Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update | Press release | +1.00% | -0.05% | |
| Form 10-Q Gossamer Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.68% | -1.77% | |
| Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update | Press release | -4.68% | -1.77% | |
| Form 10-K Gossamer Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.04% | +0.69% | |
| Form 10-Q Gossamer Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.69% | -8.99% | |
| Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update | Press release | -1.69% | -8.99% |
Keep exploring
More GOSS: analyst actions → · SEC filings → · GOSS overview →